Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Genes that modify the natural suppressive ability of myoepithelial cells: 3D co-culture siRNA screen
Assay data:18 Active, 83 Tested
Summary
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
RNAi screen for vemurafenib enhancers in BRAFV600 melanoma - Secondary Screen
Assay data:623 Active, 1600 Tested
Primary screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:91 Active, 714 Tested
Validation screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:72 Active, 208 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW620)
Assay data:15 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC5)
Assay data:11 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (DIFI)
Assay data:96 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (HT115)
Assay data:88 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (COLO320HSR)
Assay data:11 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (SW1116)
Assay data:122 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (LS180)
Assay data:67 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCT15)
Assay data:18 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CAR1)
Assay data:9 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT55)
Assay data:20 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RCM1)
Assay data:13 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (CAR1)
Assay data:45 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (COLO678)
Assay data:40 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (CL40)
Assay data:43 Active, 160 Tested
A screen to identify synergistic combinations in colorectal cancer - Secondary Screen (NCIH716)
Assay data:46 Active, 160 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on